Closing in 5 days

SNE/Scientific Specialist (Veterinary Biologicals and Emerging Therapies) - European Medicines Agency (Amsterdam)

Contract TypeSeconded National Expert
Deadline21 September 2026

About this position

The summary below is published by European Medicines Agency on the official vacancy notice. Our own analysis — salary realism, comparable openings, career trajectory, language profile — follows further down the page.

Type of position:Seconded National Expert

Job Type:21 September 2026 at 23.59 CET

Type of position: Seconded National Expert

Reference:EMA/SNE/11587

Job title:SNE/Scientific Specialist (Veterinary Biologicals and Emerging Therapies)

Deadline for applications:21 September 2026 at 23.59 CET

The European Medicines Agency is a decentralized body of the European Union with all its offices and Headquarters based in Amsterdam, the Netherlands.Its core responsibility is the protection and promotion of public health through the evaluation and supervision of medicines.

We are looking for National experts on secondment. This means staff from other European public-sector bodies can work at the European Medicines Agency (EMA) for short periods of time through the national expert on secondment (SNE) programme. The aim of this programme is to enhance and develop the relationship between European public administrations.

SNEs serve a dual role: they bring their expertise to EMA and take back to their home administration the knowledge acquired during their period of secondment. SNEs remain in the service of their employer. Secondment is not equivalent to employment, nor does it lead to…

Excerpt shown; read the full notice on the official page. The structured breakdown below covers the key facts.

Key responsibilities

According to the vacancy notice, the role centres on the following duties:

  • Support the scientific and procedural management of marketing authorisation applications for veterinary biologicals, including immunologicals, and novel veterinary therapies
  • Contribute to the assessment, implementation, and lifecycle monitoring of Risk Management Plans (RMPs) for novel therapies
  • Support the development and implementation of the regulatory framework for novel therapies under the Biotech Act
  • Coordinate and contribute to the classification and scientific assessment of novel veterinary products
  • Liaise with the Novel Therapies Working Party (NTWP), Operational Expert Groups (OEGs), external scientific experts, and other stakeholders
  • Contribute to interactions with the European Commission and the European medicines regulatory network on veterinary medicines and novel therapies
  • Contribute to the development and delivery of training and knowledge-sharing activities for the European medicines regulatory network on novel therapies and emerging technologies
  • Help identify and address evolving scientific and regulatory challenges associated with innovative veterinary medicinal products

Are you eligible?

Check these requirements from the notice before investing time in an application:

  • Education: Masters in a relevant field of study (Medicine or Life sciences) or Master's degree in regulatory science and/or affairs (nice to have)
  • Experience: 3 years from the time when a university degree was awarded on completion of a minimum of three years of study; Experience in either a competent authority in the field of medicines regulation, the pharmaceutical industry, national ethics body or in a healthcare / academic setting in the scientific, regulatory, or procedural aspects of the research, development, authorisation, production or supervi…
  • Languages: English (C1), Official language of the EU (B2)
  • Key skills: Critical review and drafting of scientific and regulatory documents for experts and lay audiences, Presenting scientific or regulatory matters at high level, Knowledge and understanding of EU pharmaceutical legislation on the regulatory framework for pharmaceutical products in the EU, Understanding of medicines regulation
  • Eligibility: Full rights as a citizen of an EU Member State, Iceland, Lichtenstein, Norway, Republic of Moldova or Ukraine; Currently employed in the public sector (such as a public intergovernmental organisation (IGO) national / regional / local public administration) in an EU Member State and due to remain in such employment for the foreseen duration of the SNE position

Contract and working arrangements

Contract duration: Between six months and two years, renewable once or more, up to a total of four years.

Hiring unit: Veterinary Biologicals and Emerging Therapies department (V-EI-BIO).

Position overview

This is the official EU Careers listing for SNE/Scientific Specialist (Veterinary Biologicals and Emerging Therapies) at EMA based in Amsterdam (Seconded National Expert).

Type of position:Seconded National Expert

Job Type:21 September 2026 at 23.59 CET

Type of position: Seconded National Expert

Reference:EMA/SNE/11587

Job title:SNE/Scientific Specialist (Veterinary Biologicals and Emerging Therapies)

Deadline for applications:21 September 2026 at 23.59 CET

The European Medicines Agency is a decentralized body of the European Union with all its offices and Headquarters based in Amsterdam, the Netherlands.Its core responsibility is the protection and promotion of public health through the evaluation and supervision of medicines.

We are looking for National experts on secondment. This means staff from other European public-sector bodies can work at the European Medicines Agency (EMA) for short periods of time through the national expert on secondment (SNE) programme. The aim of this programme is to enhance and develop the relationship between European public administrations.

SNEs serve a dual role: they bring their expertise to EMA and take back to their home administration the knowledge acquired during their period of secondment. SNEs remain in the service of their employer. Secondment is not equivalent to employment, nor does it lead to employment by EMA.Periods of secondment may last between six months and two years. This is renewable once or more,up to a total of four years.

This announcement is governed by the Rules governing the secondment of national experts. For further information please visit ourCareers portal./1434759733/)

About this position:

The European Medicines Agency (EMA) is seeking a motivated Seconded National Expert (SNE) to join the Veterinary Biologicals and Emerging Therapies department (V-EI-BIO) at an exciting time of growth and transformation. As innovation in veterinary medicines accelerates, the number and complexity of marketing authorisation applications for biologicals, including immunologicals and novel therapies continue to increase. This role offers a unique opportunity to work at the forefront of regulatory science, contributing to the evaluation of novel technologies and helping shape the future regulatory framework established by the Biotech Act (BTA).

The successful candidate will play a key role in supporting the assessment and lifecycle management of novel veterinary therapies, including the development, implementation and follow-up of Risk Management Plans (RMPs), and other biological products.

The position will involve working closely with scientific committees, the Novel Therapies Working Party (NTWP), external experts and the European Commission to address complex scientific and regulatory challenges. It offers a unique opportunity to contribute to the classification and assessment of innovative veterinary products, support network-wide capacity building, and help establish processes and requirements that will underpin future regulatory activities in this rapidly evolving field.This position is ideal for professionals with a strong scientific background and an interest in veterinary biologicals, innovation, stakeholder engagement and regulatory policy. By joining EMA, you will have the opportunity to make a meaningful contribution to the development and availability of innovative veterinary medicines, while helping to strengthen Europe's preparedness for the next generation of veterinary medicines.

In this role you will:

- Support the scientific and procedural management of marketing authorisation applications for veterinary biologicals, including immunologicals, and novel veterinary therapies. - Contribute to the assessment, implementation, and lifecycle monitoring of Risk Management Plans (RMPs) for novel therapies.Support the development and implementation of the regulatory framework for novel therapies under the Biotech Act, helping ensure organisational readiness for future legal requirements. - Coordinate and contribute to the classification and scientific assessment of novel veterinary products, providing case-by-case scientific input and regulatory recommendations.Liaise with the Novel Therapies Working Party (NTWP), Operational Expert Groups (OEGs), external scientific experts, and other stakeholders to facilitate scientific discussions and regulatory decision-making. - Contribute to interactions with the European Commission and the European medicines regulatory network on matters related to veterinary medicines and novel therapies. - Contribute to the development and delivery of training and knowledge-sharing activities for the European medicines regulatory network on novel therapies and emerging technologies.Help identify and address evolving scientific and regulatory challenges associated with innovative veterinary medicinal products, contributing to the continuous development of regulatory practices and guidance.

Apply if you meet these eligibility criteria:

1. Enjoy full rights as a citizen of an EU Member State, Iceland, Lichtenstein, Norway, Republic of Moldova or Ukraine; 2. Have a thorough knowledge of English (at least level C1) and a satisfactory knowledge of another official language of the EU (at least level B2); 3. Are currently employed in the public sector (such as a public intergovernmental organisation (IGO) national / regional /local public administration) in an EU Member State and are due to remain in such employment for the foreseen duration of the SNE position.

Essential requirements

Experience

- 3 years from the time when a university degree was awarded on completion of a minimum of three years of study; - Experience in either a competent authority in the field of medicines regulation, the pharmaceutical industry, national ethics body or in a healthcare / academic setting should have been obtained in: - The scientific, regulatory, or procedural aspects of the research, development, authorisation, productions or supervision of human or veterinary medicines - Working with medicinal products containing medical devices and associated regulatory framework.

Skills & Knowledge

- Critical review and drafting of scientific and regulatory documents for experts and lay audiences - Presenting scientific or regulatory matters at high level - Knowledge and understanding of The EU pharmaceutical legislation on the regulatory framework for pharmaceutical products in the EU.

These are considered as nice to have:

Education

- Masters in a relevant field of study (Medicine or Life sciences); - Master’s degree in regulatory science and/or affairs.

Field of study

- Scientific background relevant to perform the role.

- In information analysis and reporting on scientific/regulatory matters; - Clinical experience in a therapeutic field; - Pharmaceutical development experience; - With medicines assessment at a National Competent Authority; - Regulatory scientists/product manager experience; - Non-clinical experience; - Experience in the preparation and/or review of any part of a clinical trial application dossier or scientific advice application; - Experience in working with stakeholders (industry and national/international authorities) Skills & Knowledge

Understanding of medicines regulation.

Application timeline

This vacancy was first listed on 8 September 2026, 7 days ago.

The application deadline is 21 September 2026, 4 days from today. Late applications are not accepted, so submit through the official EU Careers portal well in advance.

Last verified against the EU Careers feed on 15 September 2026.

Where to learn more

For headcount, mission, and other open vacancies at EMA see the EMA institution page; for the cost of living, correction coefficient, and other postings in Amsterdam see our Amsterdam location page.

New to EU careers? Our beginner's guide walks through entry routes, EPSO competitions, and what to prepare. For application logistics see application tips and EPSO competitions.

Career trajectory

Career progression for this grade staff is governed by Articles 44 to 46 of the Staff Regulations (consolidated text on EUR-Lex) and Annex IB on the promotion procedure. Step increases are automatic every two years (Art. 44); grade promotion is competitive, based on the appraisal exercise (Art. 45) and the Career Development Review. For roles at EMA, progression to the next grade typically takes three to five years on merit, with two-yearly step increases in between. Article 46 governs the classification at recruitment, which sets the starting step within the grade (usually step 1 for external recruits without prior EU service, step 2 or 3 where relevant professional experience is recognised).
Mobility within the institutions is encouraged via the inter-institutional and intra-institutional vacancy publication system: temporary agents who pass the probation period and reservists from EPSO laureate lists can typically apply to internal vacancies after one year of service. Lateral moves between Directorates-General reset the seniority clock for promotion only if the new post carries a different grade.

Language profile

Beyond the formal language requirements stated in the vacancy notice, the day-to-day working languages at this employer are English and French in roughly equal measure, with German appearing in some technical files. Internal meetings and most policy drafting in Brussels run in English; French remains the preferred internal language in Luxembourg-based services and parts of DG TRADE.

Application cadence

EMA has not advertised another comparable role with the same grade and subject signature in the past twenty-four months. This opening has rarely been seen on the EU Careers feed and may be the first such posting in our two-year window. Applicants who pass the eligibility checks should not assume the same profile will reopen on a predictable cadence.

Source: This job listing was sourced from the officialEU Careers portal (EPSO). First published: .

Remove ads and unlock all featuresGo Premium